A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus

Christopher Fawsitt*, Peter Vickerman, Graham S Cooke, Nicky Welton, STOP-HCV Consortium

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

4 Citations (Scopus)
15 Downloads (Pure)

Fingerprint Dive into the research topics of 'A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus'. Together they form a unique fingerprint.

Medicine & Life Sciences